Annual CFF
$1.46 M
-$5.57 M-79.18%
31 December 2023
Summary:
Profound Medical annual cash flow from financing activities is currently $1.46 million, with the most recent change of -$5.57 million (-79.18%) on 31 December 2023. During the last 3 years, it has fallen by -$85.97 million (-98.33%). PROF annual CFF is now -98.33% below its all-time high of $87.43 million, reached on 31 December 2020.PROF Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$665.00 K
+$10.00 K+1.48%
01 September 2024
Summary:
Profound Medical quarterly cash flow from financing activities is currently -$665.00 thousand, with the most recent change of +$10.00 thousand (+1.48%) on 01 September 2024. Over the past year, it has dropped by -$476.00 thousand (-251.85%). PROF quarterly CFF is now -101.49% below its all-time high of $44.72 million, reached on 30 September 2020.PROF Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$18.55 M
-$476.00 K-2.50%
01 September 2024
Summary:
Profound Medical TTM cash flow from financing activities is currently $18.55 million, with the most recent change of -$476.00 thousand (-2.50%) on 01 September 2024. Over the past year, it has increased by +$9.59 million (+106.98%). PROF TTM CFF is now -78.78% below its all-time high of $87.43 million, reached on 31 December 2020.PROF TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PROF Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -79.2% | -251.8% | +107.0% |
| 3 y3 years | -98.3% | -114.8% | +42.6% |
| 5 y5 years | -94.7% | -108.5% | +229.0% |
PROF Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -98.3% | at low | -103.3% | +1.5% | -5.8% | >+9999.0% |
| 5 y | 5 years | -98.3% | at low | -101.5% | +1.5% | -78.8% | >+9999.0% |
| alltime | all time | -98.3% | at low | -101.5% | +65.2% | -78.8% | +621.1% |
Profound Medical Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$665.00 K(-1.5%) | $18.55 M(-2.5%) |
| June 2024 | - | -$675.00 K(-103.3%) | $19.03 M(-3.4%) |
| Mar 2024 | - | $20.38 M(-4251.3%) | $19.70 M(+1245.8%) |
| Dec 2023 | $1.46 M(-79.2%) | -$491.00 K(+159.8%) | $1.46 M(-83.7%) |
| Sept 2023 | - | -$189.00 K(<-9900.0%) | $8.96 M(-3.0%) |
| June 2023 | - | $0.00(-100.0%) | $9.24 M(-0.1%) |
| Mar 2023 | - | $2.14 M(-69.4%) | $9.25 M(+31.6%) |
| Dec 2022 | $7.03 M(+18.2%) | $7.01 M(+7774.2%) | $7.03 M(<-9900.0%) |
| Sept 2022 | - | $89.00 K(+888.9%) | -$65.00 K(-101.5%) |
| June 2022 | - | $9000.00(-112.0%) | $4.33 M(-7.4%) |
| Mar 2022 | - | -$75.00 K(-14.8%) | $4.67 M(-21.5%) |
| Dec 2021 | $5.95 M(-93.2%) | -$88.00 K(-102.0%) | $5.95 M(-54.3%) |
| Sept 2021 | - | $4.48 M(+1158.1%) | $13.01 M(-75.6%) |
| June 2021 | - | $356.00 K(-70.4%) | $53.25 M(-1.1%) |
| Mar 2021 | - | $1.20 M(-82.8%) | $53.85 M(-38.4%) |
| Dec 2020 | $87.43 M(+1225.1%) | $6.97 M(-84.4%) | $87.43 M(+9.6%) |
| Sept 2020 | - | $44.72 M(+4549.0%) | $79.80 M(+86.2%) |
| June 2020 | - | $962.00 K(-97.2%) | $42.86 M(+2.8%) |
| Mar 2020 | - | $34.78 M(-5303.3%) | $41.69 M(+531.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $6.60 M(-76.3%) | -$668.40 K(-108.6%) | $6.60 M(+17.0%) |
| Sept 2019 | - | $7.79 M(-3803.2%) | $5.64 M(+26.6%) |
| June 2019 | - | -$210.40 K(-33.2%) | $4.45 M(+18.0%) |
| Mar 2019 | - | -$314.80 K(-80.7%) | $3.77 M(-86.4%) |
| Dec 2018 | $27.81 M(+471.2%) | -$1.63 M(-124.6%) | $27.81 M(-3.2%) |
| Sept 2018 | - | $6.61 M(-843.2%) | $28.73 M(-1.6%) |
| June 2018 | - | -$888.80 K(-103.7%) | $29.20 M(+2.1%) |
| Mar 2018 | - | $23.72 M(-3460.3%) | $28.60 M(+487.4%) |
| Dec 2017 | $4.87 M(-58.8%) | -$705.90 K(-110.0%) | $4.87 M(-72.3%) |
| Sept 2017 | - | $7.07 M(-575.3%) | $17.60 M(+67.3%) |
| June 2017 | - | -$1.49 M(>+9900.0%) | $10.52 M(-12.3%) |
| Mar 2017 | - | -$8200.00(-100.1%) | $11.99 M(+1.4%) |
| Dec 2016 | $11.83 M(-36.8%) | $12.03 M(<-9900.0%) | $11.83 M(-813.1%) |
| Sept 2016 | - | -$10.70 K(-38.2%) | -$1.66 M(-53.4%) |
| June 2016 | - | -$17.30 K(-89.9%) | -$3.56 M(-119.2%) |
| Mar 2016 | - | -$170.80 K(-88.3%) | $18.56 M(-0.9%) |
| Dec 2015 | $18.73 M | -$1.46 M(-23.6%) | $18.73 M(-7.2%) |
| Sept 2015 | - | -$1.91 M(-108.7%) | $20.19 M(-8.7%) |
| June 2015 | - | $22.10 M | $22.10 M |
FAQ
- What is Profound Medical annual cash flow from financing activities?
- What is the all time high annual CFF for Profound Medical?
- What is Profound Medical annual CFF year-on-year change?
- What is Profound Medical quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Profound Medical?
- What is Profound Medical quarterly CFF year-on-year change?
- What is Profound Medical TTM cash flow from financing activities?
- What is the all time high TTM CFF for Profound Medical?
- What is Profound Medical TTM CFF year-on-year change?
What is Profound Medical annual cash flow from financing activities?
The current annual CFF of PROF is $1.46 M
What is the all time high annual CFF for Profound Medical?
Profound Medical all-time high annual cash flow from financing activities is $87.43 M
What is Profound Medical annual CFF year-on-year change?
Over the past year, PROF annual cash flow from financing activities has changed by -$5.57 M (-79.18%)
What is Profound Medical quarterly cash flow from financing activities?
The current quarterly CFF of PROF is -$665.00 K
What is the all time high quarterly CFF for Profound Medical?
Profound Medical all-time high quarterly cash flow from financing activities is $44.72 M
What is Profound Medical quarterly CFF year-on-year change?
Over the past year, PROF quarterly cash flow from financing activities has changed by -$476.00 K (-251.85%)
What is Profound Medical TTM cash flow from financing activities?
The current TTM CFF of PROF is $18.55 M
What is the all time high TTM CFF for Profound Medical?
Profound Medical all-time high TTM cash flow from financing activities is $87.43 M
What is Profound Medical TTM CFF year-on-year change?
Over the past year, PROF TTM cash flow from financing activities has changed by +$9.59 M (+106.98%)